Rockwell Medical names Raymond Pratt CMO
This article was originally published in Scrip
Executive Summary
Dr Raymond Pratt has joined Rockwell Medical, a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with innovative products, as chief medical officer. Dr Pratt previously worked at Shire Pharmaceutical Development from 2003-2010, most recently as vice-president of R&D and the scientific leader in the emerging business unit and renal business unit.